These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4517136)

  • 1. Overeating and obesity from damage to a noradrenergic system in the brain.
    Ahlskog JE; Hoebel BG
    Science; 1973 Oct; 182(4108):166-9. PubMed ID: 4517136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overeating after midbrain 6-hydroxydopamine: prevention by central injection of selective catecholamine reuptake blockers.
    Hernandez L; Hoebel BG
    Brain Res; 1982 Aug; 245(2):333-43. PubMed ID: 6812851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished amphetamine anorexia and enhanced fenfluramine anorexia after midbrain 6-hydroxydopamine.
    Ahlskog JE; Randall PK; Hernandez L; Hoebel BG
    Psychopharmacology (Berl); 1984; 82(1-2):118-21. PubMed ID: 6420820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food intake and amphetamine anorexia after selective forebrain norepinephrine loss.
    Ahlskog JE
    Brain Res; 1974 Dec; 82(2):211-40. PubMed ID: 4374293
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in body weight and food-related behaviour induced by destruction of the ventral or dorsal noradrenergic bundle in the rat.
    Sahakian BJ; Winn P; Robbins TW; Deeley RJ; Everitt BJ; Dunn LT; Wallace M; James WP
    Neuroscience; 1983 Dec; 10(4):1405-20. PubMed ID: 6607427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histochemical and pharmacological analysis of noradrenergic projections to the paraventricular hypothalamus in relation to feeding stimulation.
    Leibowitz SF; Brown LL
    Brain Res; 1980 Nov; 201(2):289-314. PubMed ID: 7417844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic hyperphagia prevented by damage to brain dopamine-containing neurons.
    Rowland N; Marshall JF; Antelman SM; Edwards DJ
    Physiol Behav; 1979 Apr; 22(4):635-40. PubMed ID: 482403
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of hypothalamic noradrenergic neurons in food intake regulation.
    Slangen JL
    Prog Brain Res; 1974; 41():395-407. PubMed ID: 4445511
    [No Abstract]   [Full Text] [Related]  

  • 9. Food intake and lateral hypothalamic self-stimulation covary after medial hypothalamic lesions or ventral midbrain 6-hydroxydopamine injections that cause obesity.
    Hernandez L; Hoebel BG
    Behav Neurosci; 1989 Apr; 103(2):412-22. PubMed ID: 2495804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascending catecholamine pathways and amphetamine-induced locomotor activity: importance of dopamine and apparent non-involvement of norepinephrine.
    Roberts DC; Zis AP; Fibiger HC
    Brain Res; 1975 Aug; 93(3):441-54. PubMed ID: 1236760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histochemical and pharmacological analysis of catecholaminergic projections to the perifornical hypothalamus in relation to feeding inhibition.
    Leibowitz SF; Brown LL
    Brain Res; 1980 Nov; 201(2):315-45. PubMed ID: 7417845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperphagia induced in geese by intraventricular injections of 6-hydroxydopamine].
    Auffray P; Marcilloux JC; Bahy C; Albe-Fessard D
    C R Acad Hebd Seances Acad Sci D; 1973 Jan; 276(3):347-50. PubMed ID: 4197480
    [No Abstract]   [Full Text] [Related]  

  • 13. Mesolimbicocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats.
    Fink JS; Smith GP
    Brain Res; 1980 Oct; 199(2):359-84. PubMed ID: 7417789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperphagia and obesity produced by midbrain lesions in the rat: a comparison with hypothalamic hyperphagia and obesity.
    Box BM; Bascom R; Mogenson GJ
    Behav Neural Biol; 1979 Jul; 26(3):330-41. PubMed ID: 486029
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the effects of intracranial injections of 6-OHDA and guanethidine on consummatory behavior and monoamine depletion.
    Singer G; Armstrong S; Evans B; Burnstock G
    Pharmacol Biochem Behav; 1975; 3(1 Suppl):91-106. PubMed ID: 1226403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amygdalar noradrenergic and dopaminergic mechanisms in the regulation of hunger and thirst-motivated behavior.
    Lénárd L; Hahn Z
    Brain Res; 1982 Feb; 233(1):115-32. PubMed ID: 6800562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphetamine-induced hyperphagia and obesity caused by intraventricular or lateral hypothalamic injections in rats.
    Hernandez L; Parada M; Hoebel BG
    J Pharmacol Exp Ther; 1983 Nov; 227(2):524-30. PubMed ID: 6579283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dorsal bundle extinction effect:dependence on subtle changes in acquisition.
    Mason ST; Fibiger HC
    Brain Res; 1979 Apr; 166(2):341-8. PubMed ID: 427593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of selective lesions of brain noradrenergic systems on the development of barbiturate tolerance in rats.
    Tabakoff B; Ritzmann RF; Oltmans GA
    Brain Res; 1979 Nov; 176(2):327-36. PubMed ID: 497811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic obesity: the myth of the ventromedial nucleus.
    Gold RM
    Science; 1973 Nov; 182(4111):488-90. PubMed ID: 4795550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.